Participation rates in cancer survivorship care (CSC) programs are suboptimal and reasons for non-attendance are poorly understood.
To identify possible improvements of the Dutch CSC for Hodgkin lymphoma (HL) survivors, we aimed to (1) identify survivor and treatment characteristics associated with non-attendance at Dutch CSC clinics for HL survivors and (2) evaluate reasons for non-attendance.
